颅内分支动脉粥样硬化病变的治疗  

Treatment of intracranial branch athemmatous disease

作　　者：彭想想 周志明 

机构地区：[1]弋矶山医院神经内科,芜湖241000

出　　处：《国际脑血管病杂志》2016年第8期756-759,共4页International Journal of Cerebrovascular Diseases

基　　金：国家自然科学基金（81171110）

摘　　要：分支动脉粥样硬化病变（branch atheromatous disease，BAD）是穿支动脉入口处或起始部由于动脉粥样硬化导致管腔狭窄或闭塞所致的一种脑深部梗死，临床上较为常见，且在急性期常有进展加重或波动的临床特征，其预后欠佳，给家庭和社会带来沉重的负担，因此对BAD患者的早期干预治疗十分重要。文章就BAD的治疗进展进行了综述。Branch atheromatous disease （BAD） is a deep cerebral infarction at the entrance or the origin of perforating artery because of atherosclerosis causing lumen stenosis or occlusion. It is common in clinical practice and there is often a clinical feature of progression or fluctuation in the acute phase. Its prognosis is poor and it will bring a heavy burden to the family and society. Therefore, the early intervention for patients with BAD is very important. This article reviews the treatment of BAD.

关 键 词：卒中 脑缺血 颅内动脉硬化 抗血小板聚集药 抗凝药 血栓溶解疗法 神经保护药 药物疗法 联合 危险因素 

分 类 号：R743.1[医药卫生—神经病学与精神病学]